Disseminated Mycobacterium haemophilum infection in a 72-year-old patient with rheumatoid arthritis on infliximab

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Collins, C Scott ^a   Terrell, Christine ^a   Mueller, Paul ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; AMIKACIN; AZITHROMYCIN; CD3 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DIURETIC AGENT; DOXYCYCLINE; GLUCOCORTICOID; INFLIXIMAB; METHOTREXATE; MINOCYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RIFAMPICIN; STEROID; WARFARIN;

AGED; ANTIBIOTIC RESISTANCE; ARTHRALGIA; ARTICLE; AUDIOMETRY; BACTERIAL INFECTION; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CASE REPORT; CHILL; COMPRESSION THERAPY; DRUG WITHDRAWAL; DYSPNEA; ERYTHEMA NODOSUM; FEVER; FOLLOW UP; HEARING IMPAIRMENT; HEART ARRHYTHMIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEG EDEMA; LYMPHOCYTE SUBPOPULATION; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM HAEMOPHILUM; MYCOBACTERIUM HAEMOPHILUM INFECTION; NONHUMAN; PANNICULITIS; PRIORITY JOURNAL; QT INTERVAL; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN DEFECT; SKIN EXAMINATION; SUDDEN DEATH; SWEAT; TINNITUS; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84876532766     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-008034     Document Type: Article

References (9)

1. Kelley CF, Armstrong WS, Eaton ME. Disseminated Mycobacterium haemophilum infection. Lancet Infect Dis 2011;11:571-8.
2. LaBombardi VJ, Nord JA. Clinical and laboratory aspects of Mycobacterium haemophilum infections. Rev Med Microbiol 1998;9:49-54.
3. Saubolle MA, Kiehn TE, White MH, et al. Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev 1996;9:435-47.
4. Swart RM, Van Ingen J, Van Soolingen D, et al. Nontuberculous mycobacteria infection and tumor necrosis factor-alpha antagonists. Emerg Infect Dis [Case Reports Letter] 2009;15:1700-1.
5. Sompolinsky D, Lagziel A, Naveh D, et al. Mycobacterium-haemophilum Sp-Nov, a new pathogen of humans. Int J Syst Bacteriol 1978;28:67-75.
6. Winthrop KL, Chang E, Yamashita S, et al. Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review]. 2009;15:1556-61.
7. Shah MK, Sebti A, Kiehn TE, et al. Mycobacterium haemophilum in immunocompromised patients. Clin Infect Dis 2001;33:330-7.
8. Lindeboom JA, Van Coppenraet L, Van Soolingen D, et al. Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections. Clin Microbiol Rev 2011;24:701.
9. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416.